PsyBio Therapeutics (PsyBio Therapeutics) Market Cap : $0.89 Mil (As of May. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PsyBio Therapeutics's share price for the quarter that ended in Jun. 2023 was $0.02. PsyBio Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 127.54 Mil. Therefore, PsyBio Therapeutics's market cap for the quarter that ended in Jun. 2023 was $2.55 Mil.

PsyBio Therapeutics's quarterly market cap increased from Dec. 2022 ($2.94 Mil) to Mar. 2023 ($6.57 Mil) but then declined from Mar. 2023 ($6.57 Mil) to Jun. 2023 ($2.55 Mil).

PsyBio Therapeutics's annual market cap increased from . 20 ($0.00 Mil) to Dec. 2021 ($18.07 Mil) but then declined from Dec. 2021 ($18.07 Mil) to Dec. 2022 ($2.94 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PsyBio Therapeutics's Enterprise Value for Today is $0.97 Mil.

PsyBio Therapeutics Market Cap Historical Data

The historical data trend for PsyBio Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics Market Cap Chart

PsyBio Therapeutics Annual Data

Trend

Dec21

Dec22

Market Cap

18.07

2.94

PsyBio Therapeutics Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Market Cap	Get a 7-Day Free Trial							8.55	10.52	2.94	6.57	2.55

Competitive Comparison of PsyBio Therapeutics's Market Cap

For the Biotechnology subindustry, PsyBio Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PsyBio Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PsyBio Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where PsyBio Therapeutics's Market Cap falls into.

PsyBio Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

PsyBio Therapeutics's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$0.0264	*	111.338
	=	$2.94

PsyBio Therapeutics's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	$0.02	*	127.539
	=	$2.55

PsyBio Therapeutics (OTCPK:PSYBF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

PsyBio Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

PsyBio Therapeutics (PsyBio Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (OTCPK:PSYBF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

PSYB:Canada

Address

4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073

Website

https://www.psybiolife.com

PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (PsyBio Therapeutics) Headlines

From GuruFocus

PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

By PRNewswire PRNewswire • 10-11-2021

PsyBio Therapeutics Announces Uplisting to OTCQB Venture Market

By PRNewswire PRNewswire • 07-14-2021

PsyBio Announces Second Quarter Financial Results of Leo Acquisition Corp.

By GlobeNewswire GlobeNewswire • 03-02-2021